Episode 32: The Triplet Therapeutics story, from concept to birth, life & death.

Update: 2023-07-19

Description

Today we have an unusual (& long) podcast where we talk to key members of the Triplet Therapeutics management team. Triplet was founded to develop antisense oligonucleotides targeting the DNA damage response pathway that has been implicated in driving repeat disorders including Huntington's disease - the lead indication for Triplet. The team discusses the challenges in building the company and what ultimately led to it's demise.

Comments

In Channel

S2 E7: A Between the Biotech Waves Conversation with Bobby Gaspar

2025-05-0258:30

S2 E6: A Between the Biotech Waves Conversation with Steve Paul

2025-04-2556:05

S2 E5: A Between the Biotech Waves Conversation with Kent Rogers

2025-04-1701:01:38

S2 E4: A Between the Biotech Waves Conversation with Dan Lynch

2025-02-2701:01:00

S2 E3: A Between The Biotech Waves Conversation with Stan Crooke, Ionis & N-Lorem Founder

2025-02-2001:04:50

S2 E2: A Between the Biotech Waves Conversation with Peter Barrett

2025-01-3153:51

S2 Episode 1: A conversation with Matt Porteus

2025-01-2454:32

Episode 35: A Between the Biotech Waves Conversation with Mike Curtis, President & CEO of eGenesis

2024-07-0201:05:29

Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics

2023-07-1901:04:37

Episode 32: The Triplet Therapeutics story, from concept to birth, life & death.

2023-07-1901:45:49

Episode 31: A Between the Biotech Waves Conversation with Tim Yu

2023-07-0255:34

Episode 30: A Between the Biotech Waves conversation with Barry Greene, CEO of Sage Therapeutics

2023-07-0245:57

Episode 29: A Between the Biotech Waves conversation with Joel Marcus, Founder & Exec Chair of Alexandria Real Estate

2023-06-1653:19

Episode 28 A Between the Biotech Waves Conversation with Rachel Meyers

2023-06-1657:39

Episode 27 A Between the Biotech Waves Conversation with Aoife Brennan, CEO of Synlogic

2023-04-2601:06:59

Episode 26: A Between the Biotech Waves conversation with Drew Weissman

2023-02-0557:08

Episode 25: A Between the Biotech Waves conversation with Rodolphe Barrangou, the Todd R Klaenhammer Distinguished Professor at NC State University.

2023-02-0301:00:19

Episode 24: A Between the Biotech Waves conversation with John Hoffman, managing director & head of healthcare equity capital markets at Credit Suisse

2023-01-0851:38

Episode 23: A Between the Biotech Waves conversation with Jim Birchenough, Vice Chair of Wells Fargo Biopharmaceutical Inv Banking

2023-01-0856:51

A Between the Biotech Waves Conversation with Jeremy Levin, Chair & CEO of Ovid Therapeutics

2023-01-0101:11:32

00:00

1.0x

Episode 32: The Triplet Therapeutics story, from concept to birth, life & death.

#box-pro-ellipsis-176354930905159{-webkit-line-clamp:2;}Episode 32: The Triplet Therapeutics story, from concept to birth, life & death.

Episode 32: The Triplet Therapeutics story, from concept to birth, life & death.

Nessan Bermingham PhD

Episode 32: The Triplet Therapeutics story, from concept to birth, life & death.